Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Angoulvant

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Archives of Cardiovascular Diseases|April 19, 2011
Late diagnosis of incomplete Cantrell's syndrome on CT scanDenis Angoulvant, Ingrid Sanchez, Loïc Boussel
Journal of the American College of Cardiology|February 21, 2019
Optimizing DAPT Duration in High-Risk Patients After Coronary Stent Implantation: Bleeding Risk Takes It AllDenis Angoulvant, Thibaud Genet, Fabrice Ivanes
European Journal of Preventive Cardiology|October 18, 2025
Towards Precision Secondary Prevention: Pharmacogenetic Insights from the Dalcetrapib-ADCY9 PathwayAmal Aidoud, Mickael Guglieri, Denis Angoulvant
The New England Journal of Medicine|January 27, 2018
Rivaroxaban in Stable Cardiovascular DiseaseLaurent Fauchier, Arnaud Bisson, Denis Angoulvant
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 28, 2018
FOURIER to ODYSSEY: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodiesPierre Sabouret, Denis Angoulvant, Atul Pathak
The Annals of Thoracic Surgery|October 30, 2004
Invited commentaryShafie Fazel, Denis Angoulvant, Richard D Weisel
Archives of Cardiovascular Diseases|November 21, 2021
Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy?Matthieu Bailly, Maria Joao Ribeiro, Denis Angoulvant
Archives of Cardiovascular Diseases|March 25, 2020
Lipoprotein(a), the rediscovered risk factor, or how to get "back to the future"Pierre Sabouret, Denis Angoulvant, Kausik K Ray
Heart (British Cardiac Society)|April 5, 2015
Dual antiplatelet therapy after acute coronary syndrome: a cardiologist-based optimal decisionDenis Angoulvant, Theodora Bejan Angoulvant, Laurent Fauchier
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 6, 2021
NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian ViewDenis Angoulvant, Pierre Sabouret, Michael P Savage
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Archives of Cardiovascular Diseases|April 19, 2011
Late diagnosis of incomplete Cantrell's syndrome on CT scanDenis Angoulvant, Ingrid Sanchez, Loïc Boussel
Journal of the American College of Cardiology|February 21, 2019
Optimizing DAPT Duration in High-Risk Patients After Coronary Stent Implantation: Bleeding Risk Takes It AllDenis Angoulvant, Thibaud Genet, Fabrice Ivanes
European Journal of Preventive Cardiology|October 18, 2025
Towards Precision Secondary Prevention: Pharmacogenetic Insights from the Dalcetrapib-ADCY9 PathwayAmal Aidoud, Mickael Guglieri, Denis Angoulvant
The New England Journal of Medicine|January 27, 2018
Rivaroxaban in Stable Cardiovascular DiseaseLaurent Fauchier, Arnaud Bisson, Denis Angoulvant
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 28, 2018
FOURIER to ODYSSEY: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodiesPierre Sabouret, Denis Angoulvant, Atul Pathak
The Annals of Thoracic Surgery|October 30, 2004
Invited commentaryShafie Fazel, Denis Angoulvant, Richard D Weisel
Archives of Cardiovascular Diseases|November 21, 2021
Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy?Matthieu Bailly, Maria Joao Ribeiro, Denis Angoulvant
Archives of Cardiovascular Diseases|March 25, 2020
Lipoprotein(a), the rediscovered risk factor, or how to get "back to the future"Pierre Sabouret, Denis Angoulvant, Kausik K Ray
Heart (British Cardiac Society)|April 5, 2015
Dual antiplatelet therapy after acute coronary syndrome: a cardiologist-based optimal decisionDenis Angoulvant, Theodora Bejan Angoulvant, Laurent Fauchier
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 6, 2021
NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian ViewDenis Angoulvant, Pierre Sabouret, Michael P Savage
Pageof 22